Status:
COMPLETED
Hair Repigmentation During Cerebrolysin Therapy
Lead Sponsor:
Universidad Autonoma de Nuevo Leon
Collaborating Sponsors:
Hospital Universitario Dr. Jose E. Gonzalez
Conditions:
Hair Problems
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Open-label histological study of scalp biopsies from patients undergoing treatment with Cerebrolysin as therapy for cerebrovascular disease. The aim is to assess by histological techniques the causes ...
Detailed Description
Patients who fulfill the study requirements will receive the standard Cerebrolysin protocol as follows: Intravenous (iv) infusions of 5 vials per week, 2 vials on Mondays and 3 vials on Thursdays for ...
Eligibility Criteria
Inclusion
- Known neurologist prescription for Cerebrolysin treatment due ischemic or hemorrhagic stroke, traumatic brain injury or dementia.
- Age-related white or gray hair.
- Above 40 years old
- Voluntarily consents in written informed consent by the principal or legal representative
Exclusion
- Patients with a diagnosis of Chronic Kidney Disease (CKD).
- Known history of seizures, epilepsy, or hypersensitivity to one or any drug components.
- Pregnant patients.
- Patients with a history of recent treatment of hair coloring products.
Key Trial Info
Start Date :
June 2 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 23 2016
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05288465
Start Date
June 2 2014
End Date
December 23 2016
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario. Dr. José Eleuterio González
Monterrey, Nuevo León, Mexico, 64460